Puma Biotechnology (PBYI) EBIT Margin (2017 - 2026)
Puma Biotechnology's EBIT Margin came in at 13.42% for Q2 2026, up 0.77 percentage points from 12.66% a year earlier and up 21.97 percentage points from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) EBIT Margin (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Puma Biotechnology reported EBIT Margin of 13.16%, down 6.19 percentage points year-over-year; for FY2025, it came in at 16.33%, up 2.90 percentage points from FY2024.
- EBIT Margin carries a five-year change of +29.84 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was 13.44% in FY2024 (-0.42 pp), 13.85% in FY2023 (+3.45 pp), 10.40% in FY2022 (+9.89 pp) and 0.51% in FY2021 (+14.01 pp).
- The five-year range for quarterly EBIT Margin is -19.36% (Q3 2021) to 27.41% (Q3 2024).
- Year-over-year, EBIT Margin increased in six of the last eight quarters, with an average year-over-year change of +2.40 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q2 2022 (a gain of 51.42 percentage points), and the weakest in Q1 2022 (a drop of 22.16 percentage points).
- Business Quant data shows PBYI's EBIT Margin at -8.54% (Q1 2026), 22.67% (Q4 2025) and 17.57% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Puma Biotechnology | 499.78 Mn | 112.42 Mn | 44.03 Mn | 13.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.42% |
| Mar 31, 2026 | -8.54% |
| Dec 31, 2025 | 22.67% |
| Sep 30, 2025 | 17.57% |
| Jun 30, 2025 | 12.66% |
| Mar 31, 2025 | 8.66% |
| Dec 31, 2024 | 22.62% |
| Sep 30, 2024 | 27.41% |
| Jun 30, 2024 | -4.63% |
| Mar 31, 2024 | -5.25% |
| Dec 31, 2023 | 20.50% |
| Sep 30, 2023 | 15.30% |
| Jun 30, 2023 | 8.96% |
| Mar 31, 2023 | 8.27% |
| Dec 31, 2022 | 15.25% |
| Sep 30, 2022 | 4.19% |
| Jun 30, 2022 | 20.26% |
| Mar 31, 2022 | -1.63% |
| Dec 31, 2021 | 12.34% |
| Sep 30, 2021 | -19.36% |
API Access
Puma Biotechnology EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();